litlas
ログインアカウント作成

Michael W. Deininger

1997–2025 年に発表

161
論文数
42,917
被引用数
97
h 指数
160
i10 指数

被引用数

Michael W. Deininger の年別被引用数1975 年: 被引用 1 件1979 年: 被引用 6 件1998 年: 被引用 3 件1999 年: 被引用 15 件2000 年: 被引用 31 件2001 年: 被引用 36 件2002 年: 被引用 118 件2003 年: 被引用 157 件2004 年: 被引用 125 件2005 年: 被引用 173 件2006 年: 被引用 228 件2007 年: 被引用 301 件2008 年: 被引用 307 件2009 年: 被引用 315 件2010 年: 被引用 309 件2011 年: 被引用 306 件2012 年: 被引用 297 件2013 年: 被引用 360 件2014 年: 被引用 353 件2015 年: 被引用 340 件2016 年: 被引用 321 件2017 年: 被引用 283 件2018 年: 被引用 287 件2019 年: 被引用 1,025 件2020 年: 被引用 1,246 件2021 年: 被引用 1,220 件2022 年: 被引用 1,060 件2023 年: 被引用 628 件2024 年: 被引用 1,280 件2025 年: 被引用 469 件2026 年: 被引用 13 件1976〜1978 年は被引用が無いため表示していません1980〜1997 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,467 件、この内訳の 27.7%ドイツ: 引用元論文 929 件、この内訳の 7.4%イギリス: 引用元論文 856 件、この内訳の 6.8%中国: 引用元論文 852 件、この内訳の 6.8%イタリア: 引用元論文 845 件、この内訳の 6.8%フランス: 引用元論文 656 件、この内訳の 5.2%カナダ: 引用元論文 412 件、この内訳の 3.3%スイス: 引用元論文 363 件、この内訳の 2.9%オーストラリア: 引用元論文 346 件、この内訳の 2.8%スペイン: 引用元論文 340 件、この内訳の 2.7%日本: 引用元論文 296 件、この内訳の 2.4%オランダ: 引用元論文 282 件、この内訳の 2.3%
0%27.7%その他 22.9%

機関

分野

  • Medicine74%
  • Biochemistry, Genetics and Molecular Biology18.2%
  • Immunology and Microbiology3.3%
  • Computer Science1.7%
  • Chemistry0.7%
  • Pharmacology, Toxicology and Pharmaceutics0.4%
  • その他1.7%

トピック

  • Chronic Myeloid Leukemia Treatments12.6%
  • Acute Myeloid Leukemia Research8.5%
  • Chronic Lymphocytic Leukemia Research6.4%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment5.7%
  • Eosinophilic Disorders and Syndromes5.7%
  • Acute Lymphoblastic Leukemia research2.7%
  • その他58.4%

共著者

全論文

検索で開く
  1. Functional genomic landscape of acute myeloid leukaemia

    著者: Jeffrey Tyner, Cristina E. Tognon, Daniel Bottomly, Beth Wilmot, Stephen E. Kurtz, Samantha L. Savage, Nicola Long, Anna Reister Schultz, Elie Traer, Melissa L. Abel, Anupriya Agarwal, Aurora Blucher, Uma Borate, Jade Bryant, Russell T. Burke, Amy Carlos, Richie Carpenter, Joseph Carroll, Bill H. Chang, Cody Coblentz, Amanda d’Almeida, Rachel J. Cook, Alexey V. Danilov, Kim-Hien T. Dao, Michie Degnin, Deirdre DeVine, James Dibb, David K. Edwards, Christopher A. Eide, Isabel A. English, Jason Glover, Rachel Henson, Hibery Ho, Abdusebur Jemal, Kara Johnson, Ryan C. Johnson, Brian Junio, Andy Kaempf, Jessica Leonard, Chenwei Lin, Selina Qiuying Liu, Pierrette Lo, Marc Loriaux, Samuel B. Luty, Tara A. Macey, Jason D. MacManiman, Jacqueline Martinez, Motomi Mori, Dylan Nelson, Ceilidh Nichols, Jill Peters, Justin Ramsdill, Angela Rofelty, Robert Schuff, Robert P. Searles, Erik Segerdell, Rebecca L. Smith, Stephen E. Spurgeon, Tyler Sweeney, Aashis Thapa, Corinne Visser, Jake Wagner, Kevin Watanabe‐Smith, Kristen Werth, Joelle Wolf, Libbey White, Amy Yates, Haijiao Zhang, Christopher R. Cogle, Robert H. Collins, Denise C. Connolly, Michael W. Deininger, Leylah Drusbosky, Christopher S. Hourigan, Craig T. Jordan, Patricia Kropf, Tara L. Lin, Micaela Martínez, Bruno C. Medeiros, Rachel R. Pallapati, Daniel A. Pollyea, Ronan Swords, Justin M. Watts, Scott J. Weir, David L. Wiest, Ryan M. Winters, Shannon K. McWeeney, Brian Druker - Nature 2018 被引用: 1,476

  2. European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia

    著者: Andreas Hochhaus, Michele Baccarani, Richard T. Silver, CA Schiffer, Jane F. Apperley, Francisco Cervantes, R E Clark, J. E. Cortes, Michael W. Deininger, François Guilhot, Henrik Hjorth‐Hansen, Timothy P. Hughes, J. Janssen, Hagop M. Kantarjian, D. W. Kim, Richard A. Larson, J. H. Lipton, F.-X. Mahon, Jiří Mayer, Franck E. Nicolini, D Niederwieser, Fabrizio Pane, Jerald P. Radich, Delphine Réa, Johan Richter, G Rosti, Philipe Rousselot, Giuseppe Saglio, Susanne Saußele, Simona Soverini, J. L. Steegmann, Anna Turkina, Andrey Zaritskey, R. Hehlmann - Leukemia 2020 被引用: 1,510

  3. A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis

    著者: Srđan Verstovšek, Ruben A. Mesa, Jason Gotlib, Richard S. Levy, Vikas Gupta, John F. DiPersio, John Catalano, Michael W. Deininger, Carole B. Miller, Richard T. Silver, Moshe Talpaz, Elliott F. Winton, Jimmie H. Harvey, Murat O. Arcasoy, Elizabeth O. Hexner, Roger M. Lyons, Ronald Paquette, Azra Raza, Kris Vaddi, Susan Erickson‐Viitanen, Iphigenia L. Koumenis, William Sun, Victor Sandor, Hagop M. Kantarjian - New England Journal of Medicine 2012 被引用: 2,050

  4. Integrative analysis of drug response and clinical outcome in acute myeloid leukemia

    著者: Daniel Bottomly, Nicola Long, Anna Reister Schultz, Stephen E. Kurtz, Cristina E. Tognon, Kara Johnson, Melissa L. Abel, Anupriya Agarwal, Sammantha Avaylon, Erik Benton, Aurora Blucher, Uma Borate, Theodore P. Braun, Jordana Brown, Jade Bryant, Russell T. Burke, Amy Carlos, Bill H. Chang, Hyun Cho, Stephen Christy, Cody Coblentz, Aaron Cohen, Amanda d’Almeida, Rachel J. Cook, Alexey V. Danilov, Kim‐Hien T. Dao, Michie Degnin, James Dibb, Christopher A. Eide, Isabel A. English, Stuart Hagler, Heath Harrelson, Rachel Henson, Hibery Ho, Sunil K. Joshi, Brian Junio, Andy Kaempf, Yoko Kosaka, Ted Laderas, Matt Lawhead, Hyun-Jung Lee, Jessica Leonard, Chenwei Lin, Evan Lind, Selina Qiuying Liu, Pierrette Lo, Marc Loriaux, Samuel B. Luty, Julia E. Maxson, Tara A. Macey, Jacqueline Martinez, Jessica Minnier, Andrea Monteblanco, Motomi Mori, Quinlan Morrow, Dylan Nelson, Justin Ramsdill, Angela Rofelty, Alexandra Rogers, Kyle A. Romine, Peter Ryabinin, Jennifer N. Saultz, David A. Sampson, Samantha L. Savage, Robert Schuff, Robert P. Searles, Rebecca L. Smith, Stephen E. Spurgeon, Tyler Sweeney, Ronan Swords, Aashis Thapa, Karina Thiel-Klare, Elie Traer, Jake Wagner, Beth Wilmot, Joelle Wolf, Guanming Wu, Amy Yates, Haijiao Zhang, Christopher R. Cogle, Robert H. Collins, Michael W. Deininger, Christopher S. Hourigan, Craig T. Jordan, Tara L. Lin, Micaela Martínez, Rachel R. Pallapati, Daniel A. Pollyea, Anthony D. Pomicter, Justin M. Watts, Scott J. Weir, Brian Druker, Shannon K. McWeeney, Jeffrey Tyner - Cancer Cell 2022 被引用: 368

  5. Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia

    著者: Andreas Hochhaus, Richard A. Larson, François Guilhot, Jerald P. Radich, Susan Branford, Timothy P. Hughes, Michele Baccarani, Michael W. Deininger, Francisco Cervantes, Satoko Fujihara, Christine-Elke Ortmann, Hans D. Menssen, Hagop Kantarjian, Stephen G. O’Brien, Brian Druker - New England Journal of Medicine 2017 被引用: 1,259

  6. Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure

    著者: Timothy P. Hughes, Michael J. Mauro, Jörge E. Cortes, Hironobu Minami, Delphine Réa, Daniel J. DeAngelo, Massimo Breccia, Yeow-Tee Goh, Moshe Talpaz, Andreas Hochhaus, Philipp le Coutre, Oliver G. Ottmann, Michael C. Heinrich, Juan Luis Steegmann, Michael W. Deininger, Jeroen J. W. M. Janssen, François-Xavier Mahon, Yosuke Minami, David T Yeung, David M. Ross, Martin S. Tallman, Jae H. Park, Brian Druker, David Hynds, Yuyan Duan, Christophe Meille, Florence Hourcade‐Potelleret, K. Gary J. Vanasse, Fabian Lang, Dong‐Wook Kim - New England Journal of Medicine 2019 被引用: 467

  7. A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias

    著者: Jörge E. Cortes, D. W. Kim, Javier Pinilla‐Ibarz, Philipp le Coutre, Ronald Paquette, Charles Chuah, Franck E. Nicolini, Jane F. Apperley, H. Jean Khoury, Moshe Talpaz, John F. DiPersio, Daniel J. DeAngelo, Elisabetta Abruzzese, Delphine Réa, Michele Baccarani, Martin C. Müller, Carlo Gambacorti‐Passerini, Siu‐Fun Wong, Stephanie Lustgarten, Victor M. Rivera, Tim Clackson, Christopher D. Turner, Frank G. Haluska, François Guilhot, Michael W. Deininger, Andreas Hochhaus, Timothy P. Hughes, John M. Goldman, Neil P. Shah, Hagop M. Kantarjian - New England Journal of Medicine 2013 被引用: 1,124

  8. Ponatinib efficacy and safety in Philadelphia chromosome–positive leukemia: final 5-year results of the phase 2 PACE trial

    著者: Jörge E. Cortes, Dong‐Wook Kim, Javier Pinilla‐Ibarz, Philipp D. le Coutre, Ronald Paquette, Charles Chuah, Franck E. Nicolini, Jane F. Apperley, H. Jean Khoury, Moshe Talpaz, Daniel J. DeAngelo, Elisabetta Abruzzese, Delphine Réa, Michele Baccarani, Martin C. Müller, Carlo Gambacorti‐Passerini, Stephanie Lustgarten, Victor M. Rivera, Frank G. Haluska, François Guilhot, Michael W. Deininger, Andreas Hochhaus, Timothy P. Hughes, Neil P. Shah, Hagop M. Kantarjian - Blood 2018 被引用: 583

  9. AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance

    著者: Thomas O’Hare, William C. Shakespeare, Xiaotian Zhu, Christopher A. Eide, Victor M. Rivera, Frank Wang, Lauren T. Adrian, Tianjun Zhou, Wei-Sheng Huang, Qihong Xu, Chester A. Metcalf, Jeffrey Tyner, Marc Loriaux, Amie S. Corbin, Scott Wardwell, Yaoyu Ning, Jeffrey Keats, Yihan Wang, Raji Sundaramoorthi, Mathew Thomas, Dong Zhou, J. T. Snodgrass, Lois Commodore, Tomi K. Sawyer, David C. Dalgarno, Michael W. Deininger, Brian Druker, Tim Clackson - Cancer Cell 2009 被引用: 1,247

  10. Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia

    著者: Brian Druker, François Guilhot, Stephen G. O’Brien, Insa Gathmann, Hagop M. Kantarjian, Norbert Gattermann, Michael W. Deininger, Richard T. Silver, John M. Goldman, Richard M. Stone, Francisco Cervantes, Andreas Hochhaus, Bayard L. Powell, Janice Gabrilove, Philippe Rousselot, Josy Reiffers, Jan J. Cornelissen, Timothy P. Hughes, Hermine Agis, Thomas Fischer, Gregor Verhoef, John D. Shepherd, Giuseppe Saglio, Aloïs Gratwohl, Johan Lanng Nielsen, Jerald P. Radich, Bengt Simonsson, Kerry Taylor, Michele Baccarani, Charlene So, Laurie Letvak, Richard A. Larson - New England Journal of Medicine 2006 被引用: 3,481

  11. Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial

    著者: Jörge E. Cortes, Carlo Gambacorti‐Passerini, Michael W. Deininger, Michael J. Mauro, Charles Chuah, Dong‐Wook Kim, Iryna Dyagil, Nataliia Glushko, Dragana Milojković, Philipp le Coutre, Valentín García‐Gutiérrez, Laurence Reilly, Allison Jeynes-Ellis, Eric Leip, Nathalie Bardy‐Bouxin, Andreas Hochhaus, Tim H. Brümmendorf - Journal of Clinical Oncology 2017 被引用: 493

  12. Identification of Interleukin-1 by Functional Screening as a Key Mediator of Cellular Expansion and Disease Progression in Acute Myeloid Leukemia

    著者: Alyssa Carey, David K. Edwards, Christopher A. Eide, Laura F. Newell, Elie Traer, Bruno C. Medeiros, Daniel A. Pollyea, Michael W. Deininger, Robert H. Collins, Jeffrey Tyner, Brian Druker, Grover C. Bagby, Shannon K. McWeeney, Anupriya Agarwal - Cell Reports 2017 被引用: 270

  13. Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 Mutants

    著者: Christopher A. Eide, Matthew S. Zabriskie, Samantha L. Savage, Orlando Antelope, Nadeem A. Vellore, Hein Than, Anna Reister Schultz, Phillip M. Clair, Amber D. Bowler, Anthony D. Pomicter, Dongqing Yan, Anna V. Senina, Qiang Wang, Todd W. Kelley, Philippe Szankasi, Michael C. Heinrich, Jeffrey Tyner, Delphine Réa, Jean-Michel Cayuela, Dong‐Wook Kim, Cristina E. Tognon, Thomas O’Hare, Brian Druker, Michael W. Deininger - Cancer Cell 2019 被引用: 245

  14. Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial

    著者: for the COMFORT-I investigators, Srđan Verstovšek, Ruben A. Mesa, Jason Gotlib, Vikas Gupta, John F. DiPersio, John Catalano, Michael W. Deininger, Carole B. Miller, Richard T. Silver, Moshe Talpaz, Elliott F. Winton, Jimmie H. Harvey, Murat O. Arcasoy, Elizabeth O. Hexner, Roger M. Lyons, Ronald Paquette, Azra Raza, Mark M. Jones, Deanna Kornacki, Kang Sun, Hagop M. Kantarjian - Journal of Hematology & Oncology 2017 被引用: 427

  15. Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia: final results from the BFORE trial

    著者: Tim H. Brümmendorf, Jörge E. Cortes, Dragana Milojković, Carlo Gambacorti‐Passerini, Richard E. Clark, Philipp le Coutre, Valentín García‐Gutiérrez, Charles Chuah, Vamsi Kota, Jeffrey H. Lipton, Philippe Rousselot, Michael J. Mauro, Andreas Hochhaus, Rafael Hurtado Monroy, Eric Leip, Simon Purcell, Anne Yver, Andrea Viqueira, Michael W. Deininger, BFORE study investigators - Leukemia 2022 被引用: 141

  16. Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial

    著者: Amy Burd, Ross L. Levine, Amy S. Ruppert, Alice S. Mims, Uma Borate, Eytan M. Stein, Prapti A. Patel, Maria R. Baer, Wendy Stock, Michael W. Deininger, William Blum, Gary J. Schiller, Rebecca L. Olin, Mark R. Litzow, James M. Foran, Tara L. Lin, Brian Ball, Michael Boyiadzis, Elie Traer, Olatoyosi Odenike, Martha Arellano, Alison Walker, Vu H. Duong, Tibor Kovacsovics, Robert H. Collins, Abigail B. Shoben, Nyla A. Heerema, Matthew C. Foster, Jo-Anne Vergilio, Timothy J. Brennan, Christine Vietz, Eric A. Severson, Molly Miller, Leonard Rosenberg, Sonja Marcus, Ashley O. Yocum, Timothy F. Chen, Mona Stefanos, Brian Druker, John C. Byrd - Nature Medicine 2020 被引用: 192

  17. Chronic Myeloid Leukemia: Modern therapies, current challenges and future directions

    著者: Afaf E.G. Osman, Michael W. Deininger - Blood Reviews 2021 被引用: 202

  18. European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia

    著者: Nicholas C.P. Cross, Thomas Ernst, Susan Branford, Jean‐Michel Cayuela, Michael W. Deininger, Alice Fabarius, Dennis Dong Hwan Kim, Kateřina Machová Poláková, Jerald P. Radich, Rüdiger Hehlmann, Andreas Hochhaus, Jane F. Apperley, Simona Soverini - Leukemia 2023 被引用: 103

  19. The molecular biology of chronic myeloid leukemia

    著者: Michael W. Deininger, John M. Goldman, Junia V. Melo - Blood 2000 被引用: 1,620

  20. The development of imatinib as a therapeutic agent for chronic myeloid leukemia

    著者: Michael W. Deininger, Elisabeth Buchdunger, Brian Druker - Blood 2004 被引用: 1,245

  21. Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity

    著者: Amie S. Corbin, Anupriya Agarwal, Marc Loriaux, Jörge E. Cortes, Michael W. Deininger, Brian Druker - Journal of Clinical Investigation 2010 被引用: 763

  22. TNFα facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms

    著者: Angela G. Fleischman, Karl J. Aichberger, Samuel B. Luty, Thomas G.P. Bumm, Curtis L. Petersen, Shirin Doratotaj, Kavin B. Vasudevan, Dorian LaTocha, Fei Yang, Richard D. Press, Marc Loriaux, Heike L. Pahl, Richard T. Silver, Anupriya Agarwal, Thomas O’Hare, Brian Druker, Grover C. Bagby, Michael W. Deininger - Blood 2011 被引用: 287

  23. Asciminib monotherapy in patients with CML-CP without BCR::ABL1 T315I mutations treated with at least two prior TKIs: 4-year phase 1 safety and efficacy results

    著者: Michael J. Mauro, Timothy P. Hughes, Dong‐Wook Kim, Delphine Réa, Jörge E. Cortes, Andreas Hochhaus, Koji Sasaki, Massimo Breccia, Moshe Talpaz, Oliver G. Ottmann, Hironobu Minami, Yeow Tee Goh, Daniel J. DeAngelo, Michael C. Heinrich, Valle Gómez-Garcı́a de Soria, Philipp le Coutre, François‐Xavier Mahon, Jeroen J. W. M. Janssen, Michael W. Deininger, Naranie Shanmuganathan, Mark B. Geyer, Silvia Cacciatore, Fotis Polydoros, Nithya Agrawal, Matthias Hoch, Fabian Lang - Leukemia 2023 被引用: 47

  24. Ponatinib in Refractory Philadelphia Chromosome–Positive Leukemias

    著者: Jörge E. Cortes, Hagop M. Kantarjian, Neil P. Shah, Dale L. Bixby, Michael J. Mauro, Ian W. Flinn, Thomas O’Hare, Simin Hu, Narayana I. Narasimhan, Victor M. Rivera, Tim Clackson, Christopher D. Turner, Frank G. Haluska, Brian Druker, Michael W. Deininger, Moshe Talpaz - New England Journal of Medicine 2012 被引用: 770